Official recall record
Panoscreen I, II, and III Reagent Red Blood Cell, 2-4% Suspension
- Issuing authority
- Health Canada — Medical Devices
- Published
- 2024-07-04
- Country of alert
- Canada
- Alert level
- Type II
- Alert type
- recall
What the authority reported
Some vials of Panoscreen, lot 17845, exhibit an unexpected dark color (hemolysis) and darkening of the red blood cells. It has been confirmed that there is fungal growth in the vials where the hemolysis and darkening of the red blood cells has been observed. This issue is random across kits within Panoscreen lot 17845 and is not present in all vials within the kit. Fungal contamination may lead to erroneous results. Recall Start Date: June 6, 2024
What to do
Follow the instructions in the official notice — recall remedies (refund, repair, replacement, or disposal) are defined by the issuing authority and the responsible business, and they differ per recall. Do not rely on summaries, including this one.
Verify at the source:
Health Canada — Medical Devices — official record →
Record last checked against the registry on 2026-05-31.
Record last checked against the registry on 2026-05-31.
ProductGuru Recalls republishes official safety information with attribution. We are not
the issuing authority and this page is not advice. If this product is a medical device or
medication, speak to a doctor or pharmacist. Found an error?
Report it — corrections are published.